Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study
Novartis
Novartis
Isala
University Health Network, Toronto
Murdoch Childrens Research Institute
Rigel Pharmaceuticals
AstraZeneca
University Hospital, Rouen
University of Florida
Aristotle University Of Thessaloniki
Brigham and Women's Hospital
Centre Hospitalier Régional d'Orléans
University Health Network, Toronto
Tanta University
University of Wisconsin, Madison
Chongqing University Cancer Hospital
Brigham and Women's Hospital
Air Liquide Santé International
University of Miami
Assistance Publique - Hôpitaux de Paris
GT Medical Technologies, Inc.
Ottawa Hospital Research Institute